San Diego, CA, United States of America

Parisa Abedinpour


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Parisa Abedinpour: Innovator in Cancer Treatment

Introduction

Parisa Abedinpour is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative pharmaceutical compositions, she has developed methods that aim to improve the lives of patients suffering from prostate carcinoma. Her work is characterized by a commitment to advancing medical science through her inventions.

Latest Patents

Parisa Abedinpour holds 2 patents related to her research. Her latest patents include compositions and methods for the treatment of prostate carcinoma. These patents disclose 1,4-naphthoquinone analogs and pharmaceutical compositions that incorporate these analogs. The methods outlined in her patents focus on treating and ameliorating diseases associated with cancer, particularly prostate cancer. Additionally, her work includes combination therapies that involve a 1,4-naphthoquinone analog and a hormone therapy agent, providing a comprehensive approach to cancer treatment.

Career Highlights

Abedinpour is currently associated with Pellficure Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical field. Her dedication to research and development has positioned her as a key player in the fight against cancer.

Collaborations

Throughout her career, Parisa has collaborated with notable professionals in her field, including Per Borgström and Adrian Chrastina. These collaborations have further enhanced her research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Parisa Abedinpour's work exemplifies the impact of innovative thinking in the medical field. Her patents and ongoing research are paving the way for new treatments that could significantly benefit patients with prostate cancer. Her contributions highlight the importance of continued innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…